1.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 40 to 55 Sponsor: Other Protocol IDs: 1769-03-A, CZOL446E, NCT00202059
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0517, RTOG 0517, NCT00365105
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: ID03-0124, NCT00452439
|
|
4.
|
Phase: Phase III Type: Health services research, Natural history/Epidemiology, Prevention Status: Completed Age: 50 to 79 Sponsor: NCI, NHLBI Protocol IDs: 114, NCT00000611
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 2006-0960, NCT00824993
|
|
6.
|
Phase: Phase III Type: Prevention Status: Closed Age: 55 and over Sponsor: NCI, Other Protocol IDs: CAPS08-15024, NCT01052051
|
|
7.
|
Phase: Phase II Type: Natural history/Epidemiology, Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 6346, NCI-2010-00621, UWCC-6346, NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715
|
|
8.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: H06-03974, 9427-UO146-93C, NCT00593580
|
|
9.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 48 to 72 Sponsor: Other Protocol IDs: RUH IRB # PHO-0554, NCT00298545
|
|
10.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 30 to 80 Sponsor: Other Protocol IDs: 07-342, P15192, NCT00585637
|
|
11.
|
Phase: No phase specified Type: Supportive care Status: Closed Age: Postmenopausal Sponsor: Other Protocol IDs: 05-0498, NCT00263185
|
|
12.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: BRSNSTU0026, 98671, NCT00656019
|
|
13.
|
Phase: No phase specified Type: Prevention Status: Closed Age: 21 and over Sponsor: Other Protocol IDs: AAAC3089, NCT00976339
|
|
14.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 50 to 75 Sponsor: Other Protocol IDs: SAC110024, IR 7297, NCT01240213
|